Luo H - Search Results

1

CDDO-Me reveals USP7 as a novel target in ovarian cancer cells.

Qin D, Wang W, Lei H, Luo H, Cai H, Tang C, Wu Y, Wang Y, Jin J, Xiao W, Wang T, Ma C, Xu H, Zhang J, Gao F, Wu YL. Qin D, et al. Among authors: luo h. Oncotarget. 2016 Nov 22;7(47):77096-77109. doi: 10.18632/oncotarget.12801. Oncotarget. 2016. PMID: 27780924 Free PMC article.

2

Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.

Tang C, Lei H, Zhang J, Liu M, Jin J, Luo H, Xu H, Wu Y. Tang C, et al. Among authors: luo h. Cancer Biol Ther. 2018 Aug 3;19(8):715-721. doi: 10.1080/15384047.2018.1451279. Epub 2018 May 8. Cancer Biol Ther. 2018. PMID: 29708817 Free PMC article.

3

Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells.

Lei H, Jin J, Liu M, Li X, Luo H, Yang L, Xu H, Wu Y. Lei H, et al. Among authors: luo h. Leuk Res. 2018 Jan;64:17-23. doi: 10.1016/j.leukres.2017.11.007. Epub 2017 Nov 11. Leuk Res. 2018. PMID: 29149649

4

WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia.

Luo H, Jing B, Xia Y, Zhang Y, Hu M, Cai H, Tong Y, Zhou L, Yang L, Yang J, Lei H, Xu H, Liu C, Wu Y. Luo H, et al. Cancer Cell Int. 2019 Mar 13;19:56. doi: 10.1186/s12935-019-0773-6. eCollection 2019. Cancer Cell Int. 2019. PMID: 30911287 Free PMC article.

5

Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.

Lei H, Tu Y, Yang L, Jin J, Luo H, Xu H, Kang J, Zhou L, Wu Y. Lei H, et al. Among authors: luo h. Cancer Invest. 2019;37(6):242-252. doi: 10.1080/07357907.2019.1630633. Epub 2019 Jul 11. Cancer Invest. 2019. PMID: 31296070

6

RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.

Wang S, Luo H, Wang C, Sun H, Sun G, Sun N, Zeng K, Song H, Zou R, Zhou T, Cong R, Liu W, Yang L, Li D, Zhou X, Zhong X, Lin L, Jiao J, Yan G, Wang X, Min X, Cao L, Zhao Y. Wang S, et al. Among authors: luo h. Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1615-1628. doi: 10.1016/j.bbadis.2017.02.011. Epub 2017 Feb 12. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28216286 Free article.

7

USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer.

Wang S, Zhong X, Wang C, Luo H, Lin L, Sun H, Sun G, Zeng K, Zou R, Liu W, Sun N, Song H, Liu W, Zhang Q, Liao Z, Teng X, Zhou T, Sun X, Zhao Y. Wang S, et al. Among authors: luo h. Cell Death Differ. 2020 Nov;27(11):3131-3145. doi: 10.1038/s41418-020-0568-2. Epub 2020 Jun 3. Cell Death Differ. 2020. PMID: 32494025 Free PMC article.

8

MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression.

Zou R, Zhong X, Wang C, Sun H, Wang S, Lin L, Sun S, Tong C, Luo H, Gao P, Li Y, Zhou T, Li D, Cao L, Zhao Y. Zou R, et al. Among authors: luo h. Int J Biol Sci. 2015 Jul 3;11(9):992-1005. doi: 10.7150/ijbs.10918. eCollection 2015. Int J Biol Sci. 2015. PMID: 26221067 Free PMC article.

9

Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.

Lu K, Wang X, Chen Y, Liang D, Luo H, Long L, Hu Z, Bao J. Lu K, et al. Among authors: luo h. Acta Biochim Biophys Sin (Shanghai). 2018 May 1;50(5):456-464. doi: 10.1093/abbs/gmx142. Acta Biochim Biophys Sin (Shanghai). 2018. PMID: 29546355 Free article.

10

In silico identification of small molecules as novel LXR agonists for the treatment of cardiovascular disease and cancer.

Wang X, Lu K, Luo H, Liang D, Long X, Yuan Y, Wu C, Bao J. Wang X, et al. Among authors: luo h. J Mol Model. 2018 Feb 15;24(3):57. doi: 10.1007/s00894-018-3578-y. J Mol Model. 2018. PMID: 29450657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,185 results

Search Page

Filters